Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 28 device-driven procedures, CMS 2024
Not enough data yet.
Not enough data yet.
Share of surgeons' claims in surgery centers and offices.
Not enough data yet.
Today's surgeons with a 50%+ chance of no longer billing it here.
Not enough data yet.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 10 | 340+0.8%/yr | +0.8%/yr | 2.80.9× | 13% | 430 in 2030+3.8%/yr |
| Lumbar fusion | 7 | 258+4.9%/yr | +4.9%/yr | 2.10.7× | 0% | 380 in 2030+6.8%/yr |
| Cervical fusion & disc arthroplasty | 5 | 221+8.1%/yr | +8.1%/yr | 1.81.5× | 0% | 400 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 11 | 2,366−11%/yr | −11%/yr | 19.60.2× | 19% | 2,680 in 2030+2.1%/yr |
| Skin substitutes & wound grafts | 1 | 290−8.4%/yr | −8.4%/yr | 2.40.2× | 29% | 500 in 2030+9.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 10 | 623−2.3%/yr | −2.3%/yr | 5.20.5× | 92% | 780 in 2030+3.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 8 | 491+1.8%/yr | +1.8%/yr | 4.10.8× | 49% | 400 in 2030−3.2%/yr |
| Peripheral arterial intervention | 4 | 237+4%/yr | +4%/yr | 2.00.4× | 0% | 380 in 2030+8.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 8 | 607+4.7%/yr | +4.7%/yr | 5.10.8× | 8% | 750 in 2030+3.5%/yr |
| Cholecystectomy & appendectomy | 3 | 396−0.7%/yr | −0.7%/yr | 3.30.9× | 0% | 500 in 2030+3.8%/yr |
| Colorectal resection | 0 | 161−1.8%/yr | −1.8%/yr | 1.30.9× | 0% | 170 in 2030+1.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| BPH procedures | 6 | 477+20%/yr | +20%/yr | 4.00.9× | 59% | 640 in 2030+5%/yr |
| Kidney stone management | 10 | 365−1.4%/yr | −1.4%/yr | 3.00.8× | 18% | 400 in 2030+1.5%/yr |
| Hysterectomy, hysteroscopy & ablation | 2 | 275+7.4%/yr | +7.4%/yr | 2.31.0× | 26% | 220 in 2030−3.5%/yr |
| Incontinence, prolapse & sacral neuromodulation | 2 | 107−0.7%/yr | −0.7%/yr | 0.90.5× | 0% | 90 in 2030−2.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 1 | 183−1%/yr | −1%/yr | 1.50.3× | 100% | 340 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 5 | 464+1.2%/yr | +1.2%/yr | 3.90.6× | 27% | 500 in 2030+1.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 15 | 1,644+38%/yr | +38%/yr | 13.60.7× | 64% | 4,150 in 2030+17%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| EP ablation | 4 | 397+5.8%/yr | +5.8%/yr | 3.31.1× | 0% | 740 in 2030+11%/yr |
| Pacemaker, ICD & CRT implantation | 6 | 384−0.5%/yr | −0.5%/yr | 3.20.8× | 26% | 440 in 2030+2.2%/yr |
| LAA occlusion & loop recorders | 4 | 103+2.1%/yr | +2.1%/yr | 0.80.3× | 39% | 120 in 2030+2.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 9 | 512−4.6%/yr | −4.6%/yr | 4.20.9× | 0% | 550 in 2030+1.2%/yr |
| Structural heart (TAVR, TEER) | 5 | 100+16%/yr | +16%/yr | 0.80.5× | 0% | 190 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 17 | 3,008−6%/yr | −6%/yr | 25.00.5× | 85% | 3,720 in 2030+3.6%/yr |
| Vitreoretinal surgery | 1 | 154−1%/yr | −1%/yr | 1.30.5× | 100% | 130 in 2030−3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 57 | 10,213+5.1%/yr | +5.1%/yr | 85.00.8× | 43% | 11,900 in 2030+2.5%/yr |
| ERCP & endoscopic ultrasound | 4 | 213+6.2%/yr | +6.2%/yr | 1.80.5× | 0% | 220 in 2030+0.8%/yr |
| Bronchoscopy & lung nodule | 2 | 179+25%/yr | +25%/yr | 1.50.6× | 0% | 660 in 2030+24%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.